About Cogniwell Pharmaceuticals Private Limited
Data last updated:
Cogniwell Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2016PTC092566. Its GSTIN is 29AAGCC4387D1ZI (Karnataka).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Karthika Balachandran and Naveen Nagarajan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.32 Katha No. 163 Dasarahalli Village K.R. Pura Hobli Mariyanna Palya, Bangalore, Karnataka, India – 560024.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.43 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹10.45 Lakh (net margin 7.3%) and EBITDA of ₹19.08 Lakh (EBITDA margin 13.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cogniwell.com.
Company details
Contact details
Cogniwell Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is cogniwell.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.32 Katha No. 163 Dasarahalli Village K.R. Pura Hobli Mariyanna Palya, Bangalore, Karnataka, India – 560024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cogniwell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cogniwell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cogniwell Pharmaceuticals Private Limited, buy the company report.
Financials of Cogniwell Pharmaceuticals Private Limited
FY 2024 filings availableCogniwell Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (down 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 28% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cogniwell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cogniwell Pharmaceuticals Private Limited
Cogniwell Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karthika Balachandran Also directs: Junedreams Studios LLP | Director | 01 Jul 2020 | 6 Years 3 Months | Current |
| Naveen Nagarajan | Director | 27 Apr 2016 | 10 Years 6 Months | Current |
Peer comparison
Cogniwell Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atrol Pharmaceuticals Private Limited | ₹1.44 Cr (FY 2025) | 935.0% | Bangalore, Karnataka, India | |||
| Cytocare Formulations Private Limited | ₹1.44 Cr (FY 2025) | 39.0% | Kolkata, West Bengal, India | |||
| Cogniwell Pharmaceuticals Private Limitedthis company | ₹1.43 Cr (FY 2024) | ₹10.45 Lakh | 7.3% | -28.0% | 7 | Bangalore, Karnataka, India |
| Skinzone Pharmaceuticals India Private Limited | ₹1.43 Cr (FY 2025) | 44.0% | Thane, Maharashtra, India | |||
| Voc&Loc Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2025) | -4.0% | Chandigarh, India |
To see the full peer comparison of Cogniwell Pharmaceuticals Private Limited, buy the company report.
Auditor
Cogniwell Pharmaceuticals Private Limited is audited by L M P & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L M P & ASSOCIATES | FY 2022 | 015450S |
Shareholding
The shareholding of Cogniwell Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cogniwell Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jan 2020 | 100325644 | Others | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Cogniwell Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by Ms Alencure Biotech Pvt Ltd | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by M/S Associated Biotech | Pending |
To see the full case history of Cogniwell Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cogniwell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cogniwell Pharmaceuticals Private Limited has a workforce of 7 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Cogniwell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCC4387D1ZI | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cogniwell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cogniwell Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Donimadagu Papireddy Rajagopal Reddy ceased to be Director on 28 Jan 2021.
Frequently asked questions
Cogniwell Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2016 (10+ years old) and is registered under CIN U51909KA2016PTC092566.
Cogniwell Pharmaceuticals has 2 current directors:
- Karthika Balachandran - Director
- Naveen Nagarajan - Director
The latest financial statements of Cogniwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Cogniwell Pharmaceuticals is 29AAGCC4387D1ZI, registered in Karnataka.
The CIN (Corporate Identification Number) of Cogniwell Pharmaceuticals is U51909KA2016PTC092566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cogniwell Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Cogniwell Pharmaceuticals was incorporated on 27 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Cogniwell Pharmaceuticals by revenue are Atrol Pharmaceuticals Private Limited, Cytocare Formulations Private Limited, Skinzone Pharmaceuticals India Private Limited, Voc&Loc Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Donimadagu Papireddy Rajagopal Reddy ceased to be Director on 28 Jan 2021. Karthika Balachandran was appointed as Director on 01 Jul 2020. Naveen Nagarajan was appointed as Director on 27 Apr 2016.
Cogniwell Pharmaceuticals can be reached through the website cogniwell.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Cogniwell Pharmaceuticals is at No.32 Katha No. 163 Dasarahalli Village K.R. Pura Hobli Mariyanna Palya, Bangalore, Karnataka, India – 560024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
